Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
An institution-wide investigation into labs at the Japanese research institute results in three corrections to papers published in Molecular and Cellular Biology between 2005 and 2010.
Using CRISPR-Cpf1 gene editing, researchers have fixed mutations that cause a form of muscular dystrophy in cultured human cardiomyocytes and a mouse model.
Economists explore the wheelings and dealings of universities and publishers during largely secret negotiations regarding access to scientific journals.
A method for culturing the infectious stage of the Plasmodium lifecycle could increase malaria vaccine production efficiency by tenfold, study authors say.